Technology
Health
Biotechnology

Neurocrine

1,953

$109.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.04 (-0.94%) Today
-$0.07 (-0.06%) As of 7:53 PM EST after-hours

Why Robinhood?

You can buy or sell Neurocrine and other stocks, options, ETFs, and crypto commission-free!

About NBIX

Neurocrine Biosciences, Inc. operates as a product based bio-pharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. Read More The company product includes INGREZZA. Neurocrine Biosciences was founded by Kevin C. Gorman and Wylie W. Vale on January 1992 and is headquartered in San Diego, CA.

CEO
Kevin Charles Gorman
Employees
585
Headquarters
San Diego, California
Founded
1992
Market Cap
10.12B
Price-Earnings Ratio
650.50
Dividend Yield
0.00
Average Volume
973.98K
High Today
$111.38
Low Today
$108.27
Open Price
$110.25
Volume
840.66K
52 Week High
$113.12
52 Week Low
$64.72

Collections

Technology
Health
Biotechnology
Pharmaceutical
US
North America

NBIX News

ReutersNov 10

Edited Transcript of NBIX earnings conference call or presentation 4-Nov-19 9:30pm GMT

Q3 2019 Neurocrine Biosciences Inc Earnings Call San Diego Nov 10, 2019 (Thomson StreetEvents) -- Edited Transcript of Neurocrine Biosciences Inc earnings conf
14

NBIX Earnings

-$1.12
-$0.53
$0.05
$0.64
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
$0.64 per share
Actual
$0.56 per share
Replay Earnings Call

You May Also Like

SLP
ROP
KEM
FLEH
TRIB
ABEOW
EXC
CYRXW
CSIQ
BLX
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy NBIX

Market Price$109.80
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell Neurocrine stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up